Design and synthesis of novel bioactive peptides and peptidomimetics.
Freidinger
Roger M
RM
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. roger_freidinger@merck.com
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D004151:Dipeptides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D004317:Doxorubicin / Q000737:chemistry; D015195:Drug Design; D006801:Humans; D007769:Lactams / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D008968:Molecular Conformation; D018716:Molecular Mimicry; D010455:Peptides / Q000737:chemistry*; D010456:Peptides, Cyclic / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D017430:Prostate-Specific Antigen / Q000378:metabolism; D013004:Somatostatin / Q000819:agonists; D014747:Vinblastine / Q000737:chemistry
D000970:Antineoplastic Agents; D004151:Dipeptides; D007769:Lactams; D010455:Peptides; D010456:Peptides, Cyclic; D013004:Somatostatin; D014747:Vinblastine; D004317:Doxorubicin; D017430:Prostate-Specific Antigen